A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Conditions
Advanced Solid Tumors · Breast Cancer · Non Small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Hospital(The First Affiliated Hospital of Ustc), Hefei, Anhui, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Meizhou People's Hospital（Huangtang Hospital）Meizhou Academy of Medical Sciences, Meizhou, Guangdong, China
Ghang xi Medical University Cancer Hospital, Nanning, Guangxi, China
Affiliated Hospital Of Hebei University, Baoding, Hebei, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Anyang Cancer Hospital, Anyang, Henan, China
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China
Xiangyang Central Hospital, Xiangyang, Hubei, China
The First People's Hospital of Changde City, Changde, Hunan, China
Jiangsu Province Hospital（The First Affiliated Hospital With Nanjing Medical University, Jiangsu Women And Children Health Hospital), Nanjing, Jiangsu, China
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
Affiliated Zhongshan Hospital Dalian University, Dalian, Liaoning, China
Liaoning cancer hospital &institute, Shenyang, Liaoning, China
Affiliated Zhongshan Hospital Dalian University, Jinan, Shandong, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Shanxi Cancer Hospital, Taiyuan, Shanxi, China
Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital, Sichuan, Sichuan, China
Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality, China